BioVoice News October 2022 Issue 1 Volume 3 | Page 23

Merck Life Sciences India , a science and technology company , is part of the Merck Group headquartered in Darmstadt , Germany . It operates across healthcare , life science , and electronics .

which helps create a difference to the life science industry in India . Skill development has been one of the major focus areas for Merck . M Lab™ through different training programs to ensure an adequate number of qualified personnel are available to the industry . Centre also acts as a platform to engage with customers to solve challenges in the pharmaceutical and biopharmaceutical industry .
How is the MLab enabling stakeholders in the biopharma & pharma industries ?
Managed by an experienced team of engineers and scientists , our M Lab™ Collaboration Centers allows one to explore technical solutions , test applications , assess technologies and optimize your process . It supports customers in their development process . It gives a feel and demo of infrastructure to Greenfield projects and Start ups / Emerging Biotech Accounts . Provides a hands-on experience to customers through planned and customized training . Pilot lab for nonclassified trouble shooting and process development trials to customers . Digital and advanced tools for remote troubleshooting and demonstration .
What are the bottlenecks in strong academia industry collaborations within the biotech sector in India ?
The development of a country is sometimes measured by how its academia collaborates with the industry . When scientific and technological competencies forge a strong relationship with the society and the academic fraternity , knowledge transfer is seamless and that bodes well for the overall health of a society .
In India , the Industry – Academic collaboration is in nascent stages and gaining importance . However there are bottlenecks , slowing down the rate of adoption . Academicians focus less about the implications of their research work in the industry and that hinders them from commercialising their work . On the other hand , the industry is less open to the tunnel vision of the research and academic departments and ignores the immense knowledge potential that is available to them . This I think is the biggest bottleneck within the biotech sector . Having said that , we see few academic institutions in India having good
BIOVOICENEWS . COM 23